Click to view now! Latest Q3 financial reports from the world’s top 50 chemical giants have been released.

Recently, major chemical enterprises—including BASF, Dow, and Wanhua Chemical—have successively released their third-quarter financial reports for this year. The reports show that sales performance across these companies remains generally positive; however, some firms have suffered profit setbacks due to factors such as global economic sluggishness and persistently high energy and raw material costs. Asia-Pacific Region Rongsheng Petrochemical reported Q3 operating revenue of RMB 77.491 billion, up 72.43% year-on-year; net profit attributable to shareholders was RMB 83.999 million, down 97.64% YoY. For the first three quarters, operating revenue totaled RMB 225.118 billion, up 74.03% YoY; net profit attributable to shareholders amounted to RMB 5.451 billion, down 46.15% YoY. Hengli Petrochemical reported Q3 operating revenue of RMB 51.202 billion, up 9.14% YoY; cumulative revenue for the first three quarters reached RMB 170.357 billion, up 12.46% YoY. Net profit attributable to shareholders for the first three quarters stood at RMB 6.087 billion, down 52.12% YoY—including a Q3 net loss of RMB 1.939 billion. China National Chemical Corporation (CNCEC) reported Q3 revenue of RMB 45.255 billion, up 32.8% YoY; net profit attributable to shareholders was RMB 1.071 billion, up 10.9% YoY. For the first three quarters, revenue totaled RMB 120.053 billion, up 33.4% YoY; net profit attributable to shareholders reached RMB 3.720 billion, up 28.4% YoY. Hengyi Petrochemical reported Q3 operating revenue of RMB 43.512 billion, up 20.77% YoY; net profit attributable to shareholders was -RMB 496 million, down 159.91% YoY. For the first three quarters, operating revenue totaled RMB 123.316 billion, up 26.93% YoY; net profit attributable to shareholders was RMB 1.317 billion, down 56.7% YoY. Wanhua Chemical reported Q3 operating revenue of RMB 41.302 billion, up 4.14% YoY; net profit was RMB 3.225 billion, down 46.35% YoY. For the first three quarters, operating revenue totaled RMB 130.420 billion, up 21.53% YoY; net profit was RMB 13.608 billion, down 30.36% YoY. Sinochem International reported Q3 revenue of RMB 21.5 billion, up 10.56% YoY; net profit was RMB 315 million, up 21% YoY. For the first three quarters, revenue totaled RMB 65.939 billion, up 12.83% YoY; net profit was RMB 1.29 billion, down 46.36% YoY. Yunnan Yuntianhua reported Q3 operating revenue of RMB 19.836 billion, up 18.77% YoY; net profit attributable to shareholders was RMB 1.665 billion, up 31.24% YoY. For the first three quarters, operating revenue totaled RMB 56.459 billion, up 18.53% YoY; net profit attributable to shareholders was RMB 5.130 billion, up 80.63% YoY. Oriental Shenghong reported Q3 revenue of RMB 16.466 billion, up 17.14% YoY; net profit attributable to shareholders was a loss of RMB 58.7978 million. For the first three quarters, revenue totaled RMB 46.708 billion, up 16.17% YoY; net profit attributable to shareholders was RMB 1.577 billion, down 59.99% YoY.

Value stocks are highly favored—among these three, which one has explosive upside potential?

Curiously, the coronavirus crisis may even have benefited Procter & Gamble (PG). Its strong performance in household and consumer health, personal care, and hygiene niche markets meant that demand for PG products remained robust—even amid an overall decline in consumer activity. In its first-quarter earnings report (PG’s fiscal third quarter), the company reported revenue growth of 4.2% year-on-year. Beyond its solid footing in the current environment, P&G is also one of the true dividend champions in the market. It boasts a 16-year track record of consistent dividend increases and reliable payments. The current quarterly payout stands at $0.79—raised by $0.04 in the first quarter—to an annualized rate of $3.16 per quarter, yielding 2.7%. Although this yield is only slightly above the consumer staples sector’s average of 2.5%, P&G’s long-standing dividend history and a payout ratio of 64% indicate that the dividend is comfortably sustainable at current earnings levels. Robert Ottenstein of Evercore ISI covers P&G stock and titled his report: “Better, More Resilient, Smarter.” Regarding future prospects, Ottenstein wrote, “We believe P&G is a dependable 6–8% EPS grower—and even amid unprecedented challenges, the company remains confident in raising its dividend by 6%…” Ottenstein maintains his “Buy” rating on P&G and raised his price target from $130 to $140—implying 21% upside over the next 12 months. Overall, among 10 analyst ratings, nine are “Buy,” giving P&G a consensus rating of Strong Buy. Wall Street is somewhat less aggressive than Ottenstein—but the average target price of $133 still implies 15% upside potential. Linde plc (LIN) Next is Linde, a key player in the industrial gases industry. This is not a consumer utility; rather, Linde dominates markets for pure gases (e.g., oxygen, nitrogen, hydrogen, argon) and specialty gases (e.g., carbon monoxide), all of which serve critical functions in industrial applications—especially in healthcare and HVAC—sectors deemed essential even during public health crises. Like P&G above, Linde benefits from stable niches and product lines resilient to recessionary pressures. Linde’s market strength is reflected in its quarterly results. While most companies saw share price declines or losses, Linde reported Q1 EPS flat versus Q4. That quarter’s earnings were $1.89—3.2% above expectations—and marked the fifth consecutive quarter of beating estimates. Another similarity with P&G is that Linde’s sustained profitability stems directly from its strength in the healthcare sector. Approximately 20% of its revenue comes from healthcare-related sales (e.g., oxygen for respiratory disease treatment), enabling Linde to successfully offset losses elsewhere. With stable revenue, Linde is unhesitant about announcing future dividends. The company announced a second-quarter dividend of $0.96 per share.

Linde Beats Q3 2026 Estimates for a Sixth Straight Quarter

2 days ago

Linde plc reported Q3 2026 adjusted EPS of $4.59 and revenue of $9.40 billion, exceeding consensus estimates for the sixth consecutive quarter driven by underlying sales growth and an $11 billion project backlog.

24/7 Wall St.

2026-07-30

Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates

2026-07-31

Linde Plc Expects Q3 Adjusted EPS Range $4.45 - $4.55

2026-08-02

Linde Plc Earnings Call Shows Growth Amid Margin Strain

2026-08-17

Linde Stock Holds Strong After Q2 2026 Earnings Beat and Guidance Raise

2026-08-20

Resilient Linde Stock Trades Close to Recent Highs as Q2 2026 Earnings and Guidance Support Outlook